The world's first red blood cell maturation agent: Bristol-Myers Reblozyl The world's first red blood cell maturation agent:...
Drugs
IL-30: A cytokine that promotes cancer development IL-30: A cytokine that promotes cancer development. IL-30 was discovered in 2002,...
Depression (MDD): Zuranolone quickly relieves symptoms after 2 weeks Depression (MDD): Zuranolone quickly relieves symptoms after 2 weeks. New medicine...
Tisagenlecleucel to treat adult relapsed or refractory diffuse large B-cell lymphoma Tisagenlecleucel to treat relapsed or refractory diffuse...
First-line treatment of advanced nasopharyngeal cancer by immunotherapy First-line treatment of advanced nasopharyngeal cancer by immunotherapy. A study evaluating the...
Why did FDA approve Aducanumab for AD even most experts objected? Why did FDA approve Aducanumab for AD even...
Application and Prospect of Allosteric Design in Protein Engineering Application and Prospect of Allosteric Design in Protein Engineering....
Brief introduction of ADC (Antibody-drug conjugate) clinical pharmacology Brief introduction of ADC (Antibody-drug conjugate) clinical pharmacology. Antibody-drug conjugate (ADC)...
Venclyxto+Gazyvaro for chemotherapy-free first-line treatment of CLL Venclyxto+Gazyvaro for chemotherapy-free first-line treatment of CLL. Leukemia bid farewell to chemotherapy:...
Design strategy and production optimization of RNA targeted drugs Design strategy and production optimization of RNA targeted drugs. ...
Immunomodulatory effects of targeted anticancer drugs Immunomodulatory effects of targeted anticancer drugs. In the past thirty years, a...
How to choose the subtype of antibody for tumor immunotherapy? How to choose the subtype of antibody for tumor...
Why is the approval of Alzheimer drug: Aducanumab highly controversial? Why is the approval of Alzheimer drug: Aducanumab highly...
New drugs for rare diseases! The U.S. FDA approved Ultomiris, a long-acting C5 complement inhibitor: treatment of paroxysmal nocturnal hemoglobinuria...
What are ADC immunogenicity and characteristics of ADA immune response? What are ADC immunogenicity and characteristics of ADA immune response?...
New medicine for cystic fibrosis (CF)! The US FDA approves the Vertex triple therapy Trikafta to expand the applicable population:...
Biogen New Drug Aducanumab: Will targeting TREM2 be a new hope for AD? Biogen Aducanumab: Will targeting TREM2 be a...
Targeted drug Truseltiq for cholangiocarcinoma effectively prolongs survival, orally administered Targeted drug Truseltiq for cholangiocarcinoma effectively prolongs survival. Cholangiocarcinoma is...
Exciting: Alzheimer's disease ushered in the first new drug in 18 years, FDA approved Aducanumab to market Exciting: Alzheimer's...
The first drug to delay the progression of Alzheimer's disease was approved! First drug to delay the progression...
The NK feeder cells of mIL-21 drive the strong expansion and metabolic activation of NK cells NK feeder...
Antibody cocktail REGEN-COV Emergency Use Authorization (EUA) updated: low-dose 1200mg to treat COVID-19 patients! Antibody cocktail REGEN-COV Emergency...
The best weight-loss drug in history has been approved by FDA. The monthly cost is about US$1,300/month and weight loss...
University of Edinburgh: Drugs act as a Trojan horse to kill cancer cells University of Edinburgh: Drugs act...
Is Targeting GPCR receptor complex the new direction for drug discovery? Is Targeting the GPCR receptor complex the new direction...
Genetic medicine ($2.5m./injection) rewrites the fate of a 5-month-old baby! Genetic medicine ($2.5m./injection) rewrites the fate of a 5-month-old...
Cure early lung cancer! Imfinzi demonstrates unprecedented survival benefits: treatment of unresectable stage III lung cancer, with a 5-year survival...
Lybalvi, a compound olanzapine formulation, was approved by the FDA to reduce weight gain caused by olanzapine Lybalvi...
Cell therapy for severe COVID-19 patients: clinical trials and cost-effectiveness Cell therapy for severe COVID-19 patients: clinical trials...
Star target of tumor immunity: CD137 Double Antibodies and Combo Strategy Star target of tumor immunity: CD137 Double Antibodies...